A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uab Dermatology
Birmingham, Alabama, United States
- the Regents of the University of California
Irvine, California, United States
- Medical Faculty Associates
Washington D.C., District of Columbia, United States
- Advanced Pharma, Cr, Llc
Miami, Florida, United States
- University of Miami - Department of Dermatology
Miami, Florida, United States
- Rush Medical Center
Chicago, Illinois, United States
- North Shore University Health System
Skokie, Illinois, United States
- Siu School of Medicine
Springfield, Illinois, United States
- Tulane University School of Medicine
New Orleans, Louisiana, United States
- John Hopkins University
Baltimore, Maryland, United States
- Boston Cancer Center
Boston, Massachusetts, United States
- University of Minnesota-Department of Dermatology
Minneapolis, Minnesota, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Ohio State Univ Medical Center, Division of Dermatology
Columbus, Ohio, United States
- Rhode Island Hospital University Dermatology, Inc.
Providence, Rhode Island, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Dermatology and Research
Dallas, Texas, United States
- University of Texas Dermatology
Houston, Texas, United States
- Sun Research Institute
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2011
- Primary completion
- 30 Jul 2012
- Completion
- 30 Jul 2012
- Last update posted
- 19 Nov 2019
- Registered enrollment
- 5
- Registry id
- NCT01466725
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.